RARRES2 and Insulin resistance: Chemerin is associated with markers of the metabolic syndrome in clinical cohorts and is able to induce insulin resistance in mouse models, especially in skeletal muscle while acting as an insulin-sensitizing agent in adipocytes2,13–15.